Kashiv BioSciences
ApprovedKashiv BioSciences is a fully-integrated biopharmaceutical company with global R&D, clinical, manufacturing, regulatory, and IP capabilities.
Founded
2015
Employees
201-500
Focus
Biosimilars
About
Kashiv BioSciences is a fully-integrated biopharmaceutical company with global R&D, clinical, manufacturing, regulatory, and IP capabilities.
Funding History
2Total raised: $55M
Series B$40MUndisclosedSep 15, 2021
Series A$15MUndisclosedMar 15, 2020
FDA Approved Drugs
2FYLNETRABLAMay 26, 2022
RELEUKOBLAFeb 25, 2022
Company Info
TypePrivate
Founded2015
Employees201-500
LocationChicago, United States
StageApproved
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile